周小菊 - 武汉大学

个人简介

学习简历： 1994.9 - 1998.6 同济医科大学药学院药学专业，获理学学士学位 2001.9 - 2004.6 华中科技大学同济医学院药学院，获药剂学理学硕士学位 2005.9 - 2008.12 武汉大学化学与分子科学学院，获有机化学博士学位工作简历： 1998.7 - 2001.8 武汉瑞德生物制品有限公司从事质检工作,执业药师 2004.7 - 至今武汉大学药学院从事药剂学专业的教学科研工作 2011.6 - 2012.6 美国俄亥俄州立大学药学院从事药剂学博士后研究

研究领域

新型靶向递药系统，新药开发，智能纳米载体材料的研制

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1) Xiaoju Zhou*,1, Pengyu Wang1, Jiong Wang, Zhi Liu，Xuechuan Hong, Yuling Xiao, Peng Liu, Xianming Hu. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets. Carbohydrate Polymers, 2016, 154:1-7. 2) Zhigang Rao, Hao Hu, Jiazhi Tang, Zhiying Liu, Yue Yang, Guofu Qiu, Yuling Xiao, Peng Liu, Xiaoju Zhou*, Xuechuan Hong*. Steroidal ammonium compounds as new neuromuscular blocking agents. Chemical Biology & Drug Design, 2016, 8: 73-783 3) Zhiming Wang, Jinpin Li, Xiao dong Zeng, Xianming Hu, Xiaoju Zhou,* Xuechuan Hong*. Synthesis and pharmacological evaluation of novel benzenesulfonamide derivatatives as potential anticonvulsant agents.Molecules, 2015, 20(9): 17585-17600. 4) Jing Chen, Ju Zhang, Yanxia Xiang, Limin Xiang, Xiangjiu He, Yongmei Liu, Xiaoju Zhou, Xin Liu, Zebo Huang. Extract of Tsai Tai (Brassica chinensis): Enhanced Antioxidant Activity and Anti-aging Effects both in vitro and in Caenorhabditis elegans. Food & Function, 2016, 7(2): 943-952. 5) Li-Ping Yang, Fang-Jie Jiang, Gui-Sheng Wu, Ke Deng, Meng Wen, Xiaoju Zhou, Xuechuan Hong, Michael X. Zhu, Huai-Rong Luo*. Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice. PLOS ONE, 2015, DOI:10.1371/journal.pone.0136255. 6）Xiaoju Zhou, Jiong Wang, Jianhong Wu, Xiaojuan Yang, Bryant C. Yung, L. James Lee, Robert J. Lee*. Preparation and evaluation of a novel liposomal formulation of cisplatin. European Journal of Pharmaceutical Sciences, 2015, 66: 90-95. 7）Mengzi Zhang, Xiaoju Zhou, Bo Wang, Bryant C. Yung , Ly J. Lee, Kalpana Ghoshal, Robert J. Lee*. Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. Journal of controlled release, 2013, 168: 252-261. 8）Xiaoju Zhou1, Mengzi Zhang1, Hong Li, Chenguang Zhou, Robert J. Lee*. Liver targeting and antitumor activity of doxorubicin liposomes modified with a novel galactosylated lipid. International Journal of Nanomedicine, 2012, 7: 5465–5474. 9）Xiaoju Zhou, Bryant Yung, Hong Li, Xianming Hu, Robert J. Lee*. A novel liposomal gefitinib formulation.Anticancer Research, 2012, 32(7): 2919-23. 10）Xiaoju Zhou, Yan Hu, Yanping Tian, Xianming Hu*. Effect of N-trimethyl chitosan enhancing the dissolution properties of lipophilic drug cyclosporin A. Carbohydrate Polymers, 2009, 76(2): 285-290. 11）Yan Hu, Xiaoju Zhou, Yong Lu, Chengyang Hu, Xianming Hu. Novel biodegradable hydrogels based on pachyman and its derivatives for drug delivery. International Journal of Pharmaceutics, 2009, 371: 89-98. 12）Xiaoju Zhou, Yimu Yi, Wan Jing, Xianming Hu*. Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles. Drug Development and Industrial Pharmacy, 2008，9(16): 1- 6.